OTCMKTS:BCTXF BriaCell Therapeutics (BCTXF) Stock Price, News & Analysis → Top 5 AI Stocks to Buy for 2024 (From Market Moving Trends) (Ad) Free BCTXF Stock Alerts $1.42 +0.06 (+4.41%) (As of 06/14/2024 ET) Add Compare Share Share Today's Range$1.31▼$1.4250-Day Range$1.31▼$2.9352-Week Range$3.25▼$17.50Volume63,867 shsAverage Volume1,859 shsMarket Capitalization$1.10 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartHeadlinesStock AnalysisChartHeadlines Get BriaCell Therapeutics alerts: Email Address Ad Porter & CompanyElon to Transform U.S. Economy? A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” grift of the elites. And yet, while it threatens their wealth and power, it could be transformational for both the U.S. economy and your wealth.One company holds a near-total monopoly on it. About BriaCell Therapeutics Stock (OTCMKTS:BCTXF)BriaCell Therapeutics Corp. operates as a clinical-stage biotechnology company that specializes in immunotherapy for advanced breast cancer. It is advancing its targeted immunotherapy program by conducting a Phase I/IIA clinical trial with Bria-IMT in combination with an immune checkpoint inhibitor and a companion diagnostic test, BriaDx, to identify patients to benefit from Bria-IMT. The company was founded by Charles L. Wiseman and Isaac B. Maresky on July 26, 2006 and is headquartered in West Vancouver, Canada.Read More BCTXF Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart BCTXF Stock News HeadlinesJune 9, 2024 | americanbankingnews.comBriaCell Therapeutics (OTCMKTS:BCTXF) Shares Down 3.5% May 15, 2024 | msn.comBriaCell falls on $5M stock offeringApril 21, 2024 | morningstar.comBriaCell Therapeutics Corp Ordinary Shares - New BCTFebruary 2, 2024 | msn.comBriaCell’s Shareholders Approve Directors and AuditorsJanuary 4, 2024 | finanznachrichten.deBriaCell Therapeutics Corp.: BriaCell Images Confirm Robust Anti-Tumor Activity in Patient with "Eye-Bulging" Metastatic Breast CancerNovember 15, 2023 | businesswire.comMiNA Therapeutics Highlights Preclinical Research on RNA Activation (RNAa) Therapeutics Presented at the Oligonucleotide Therapeutics Society (OTS) Annual MeetingOctober 25, 2023 | finance.yahoo.comBriaCell Forms Medical Advisory Board of Distinguished Breast Cancer Specialists to Advance its Lead Oncology CandidateOctober 20, 2023 | finance.yahoo.comOctober is Breast Cancer Awareness Month – BriaCell is Leading the Fight with its Innovative TechnologySeptember 26, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp flat on Monday (BCT)September 10, 2023 | msn.comBriaCell Therapeutics: Poised To Move To Advanced Trials, But An Unconvincing ThesisSeptember 8, 2023 | finance.yahoo.comBriaCell Reports Benchmark-Beating Patient Survival and Clinical Benefit in Advanced Metastatic Breast CancerAugust 18, 2023 | finance.yahoo.comBriaCell Therapeutics Corp. Announces Voting Results From Special MeetingAugust 17, 2023 | msn.comBriaCell receives NCI grant for cancer platform developmentJuly 22, 2023 | theglobeandmail.comBriaCell Therapeutics: Stocks Undervalued by Analyst Consensus on TSX (BCT)June 28, 2023 | markets.businessinsider.comBriaCell Therapeutics (BCT) Gets a Buy Rating from H.C. WainwrightMay 25, 2023 | marketwatch.comBriaCell Therapeutics in Definitive Agreement to Spin Off Certain AssetsMay 25, 2023 | msn.comBriaCell to spin out BriaPro TherapeuticsApril 27, 2023 | theglobeandmail.comBriaCell Therapeutics: Top 25 Performing Stocks Year-to-Date on Toronto Stock Exchange (BCT)April 7, 2023 | theglobeandmail.comClosing Bell: Briacell Therapeutics Corp down on Thursday (BCT)April 1, 2023 | morningstar.comToronto Stocks Advance as Banking Sector Sentiment Improves; BriaCell Slides on Spinoff PlansMarch 30, 2023 | marketwatch.comBriaCell Therapeutics to Spin Off Certain AssetsFebruary 23, 2023 | marketwatch.comBriaCell Sees Positive Survival Data in Ongoing TrialFebruary 23, 2023 | finance.yahoo.comBriaCell Reports Positive Survival Data in Advanced Metastatic Breast CancerJanuary 23, 2023 | marketwatch.comBriaCell to Investigate Potential Stock ManipulationJanuary 12, 2023 | stockhouse.comBriaCell Announces New Patent Issuance, Bria-OTS(TM) IND Timing Guidance, and Additional Clinical Sites to Boost EnrolmentSee More Headlines Receive BCTXF Stock News and Ratings via Email Sign-up to receive the latest news and ratings for BriaCell Therapeutics and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Pharmaceutical Preparations Sub-IndustryN/A Current SymbolOTCMKTS:BCTXF CUSIPN/A CIKN/A Webwww.briacell.com Phone(604) 921-1810FaxN/AEmployees5Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($3.84) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-3,680,000.00 Net MarginsN/A Pretax MarginN/A Return on EquityN/A Return on Assets-786.77% Debt Debt-to-Equity RatioN/A Current Ratio0.07 Quick Ratio0.07 Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / Cash FlowN/A Book Value($4.55) per share Price / Book-0.31Miscellaneous Outstanding Shares772,000Free FloatN/AMarket Cap$1.10 million OptionableNot Optionable Beta1.09 Investing Strategies To Help Grow Your Retirement IncomeNeed to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.Get This Free Report Key ExecutivesWilliam V. WilliamsPresident, Chief Executive Officer & DirectorGadi LevinChief Financial Officer & SecretaryFarrah DeanManager-Corporate Development & IR ContactKey CompetitorsCingulateNASDAQ:CINGAzitraNYSEAMERICAN:AZTRAlzamend NeuroNASDAQ:ALZNTheriva BiologicsNYSEAMERICAN:TOVXChina PharmaNYSE:CPHIView All Competitors BCTXF Stock Analysis - Frequently Asked Questions How have BCTXF shares performed in 2024? BriaCell Therapeutics' stock was trading at $5.85 at the beginning of the year. Since then, BCTXF stock has decreased by 75.7% and is now trading at $1.42. View the best growth stocks for 2024 here. How do I buy shares of BriaCell Therapeutics? Shares of BCTXF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:BCTXF) was last updated on 6/15/2024 by MarketBeat.com Staff From Our PartnersThe #1 Crypto That You Don’t Own… YetThere’s all kinds of “signals” to follow when investing in cryptos. But there’s one signal you should pay a...Crypto 101 Media | SponsoredKiss of death from Joe BidenI did not consent. You did not consent. It’s in direct violation of the U.S. Constitution but Biden does ...Porter & Company | SponsoredTiny, One-Half Inch Pellet the Key to INFINITE Energy?It’s a tiny, $1 billion company that holds the key to this power. And yet, it’s the largest company of its ...Eagle Publishing | SponsoredTop 5 Tech Stocks to Buy for 2024The next evolution of technology is already upending industries worth $7 Trillion… It's already got the world'...Daily Market Alerts | SponsoredTop 5 AI Stocks to Buy for 2024The electric vehicle boom is accelerating – and fast.Market Moving Trends | SponsoredAI's Next Magnificent SevenThe Original Magnificent Seven Produced 16,894% Average Returns Over 20 Years.The Oxford Club | SponsoredThe Only Energy Play You Should Be Looking AtOpen AI’s Sam Altman recently helped this company raise $577 million in funding… What’s more is, It has alr...Wealthpin Pro | SponsoredBill Clinton Backing Biden Replacement???Do you want to see who I believe will be the next president of the U.S.A? It won’t be Biden…And it won’t be...The Freeport Society | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BriaCell Therapeutics Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share BriaCell Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.